Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.

Inoda S, Hirohashi Y, Torigoe T, Morita R, Takahashi A, Asanuma H, Nakatsugawa M, Nishizawa S, Tamura Y, Tsuruma T, Terui T, Kondo T, Ishitani K, Hasegawa T, Hirata K, Sato N.

Am J Pathol. 2011 Apr;178(4):1805-13. doi: 10.1016/j.ajpath.2011.01.004.

2.

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.

3.

Cells of origin in cancer.

Visvader JE.

Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781. Review.

PMID:
21248838
4.

CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S.

J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17.

5.

Selection of tumorigenic melanoma cells using ALDH.

Boonyaratanakornkit JB, Yue L, Strachan LR, Scalapino KJ, LeBoit PE, Lu Y, Leong SP, Smith JE, Ghadially R.

J Invest Dermatol. 2010 Dec;130(12):2799-808. doi: 10.1038/jid.2010.237. Epub 2010 Aug 26.

6.

4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.

Sluijter BJ, van den Hout MF, Stam AG, Lougheed SM, Suhoski MM, van den Eertwegh AJ, van den Tol MP, van Leeuwen PA, Meijer S, Scheper RJ, June CH, de Gruijl TD, Santegoets SJ.

Clin Immunol. 2010 Nov;137(2):221-33. doi: 10.1016/j.clim.2010.07.009. Epub 2010 Aug 13.

PMID:
20708974
7.

Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity.

Rasper M, Schäfer A, Piontek G, Teufel J, Brockhoff G, Ringel F, Heindl S, Zimmer C, Schlegel J.

Neuro Oncol. 2010 Oct;12(10):1024-33. doi: 10.1093/neuonc/noq070. Epub 2010 Jul 13.

8.

Targeting breast cancer stem cells.

Liu S, Wicha MS.

J Clin Oncol. 2010 Sep 1;28(25):4006-12. doi: 10.1200/JCO.2009.27.5388. Epub 2010 May 24. Review.

9.

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.

Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, Hidalgo M, Maitra A, Matsui W.

J Natl Cancer Inst. 2010 Mar 3;102(5):340-51. doi: 10.1093/jnci/djp535. Epub 2010 Feb 17.

10.

Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.

Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, Mortini P, Ferrone S, Doglioni C, Marincola FM, Galli R, Parmiani G, Maccalli C.

Clin Cancer Res. 2010 Feb 1;16(3):800-13. doi: 10.1158/1078-0432.CCR-09-2730. Epub 2010 Jan 26.

11.

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.

Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME.

Head Neck. 2010 Sep;32(9):1195-201. doi: 10.1002/hed.21315.

12.

Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR, Jensen MC.

Cancer Res. 2009 Dec 1;69(23):8886-93. doi: 10.1158/0008-5472.CAN-09-2687. Epub 2009 Nov 10.

13.

Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, Ku HH, Chiou SH, Lo WL.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):307-13. doi: 10.1016/j.bbrc.2009.05.048. Epub 2009 May 18.

PMID:
19450560
14.

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM.

Cancer Res. 2009 Apr 15;69(8):3382-9. doi: 10.1158/0008-5472.CAN-08-4418. Epub 2009 Mar 31.

15.

Adoptive cell therapy for the treatment of patients with metastatic melanoma.

Rosenberg SA, Dudley ME.

Curr Opin Immunol. 2009 Apr;21(2):233-40. doi: 10.1016/j.coi.2009.03.002. Epub 2009 Mar 21. Review.

16.

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS.

Cancer Res. 2009 Feb 15;69(4):1302-13. doi: 10.1158/0008-5472.CAN-08-2741. Epub 2009 Feb 3.

17.

Stem cell concepts renew cancer research.

Dick JE.

Blood. 2008 Dec 15;112(13):4793-807. doi: 10.1182/blood-2008-08-077941. Review.

18.

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.

Visvader JE, Lindeman GJ.

Nat Rev Cancer. 2008 Oct;8(10):755-68. doi: 10.1038/nrc2499. Epub 2008 Sep 11. Review.

PMID:
18784658
19.

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Marchitti SA, Brocker C, Stagos D, Vasiliou V.

Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):697-720. doi: 10.1517/17425255.4.6.697 . Review.

20.

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G.

Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014.

Supplemental Content

Support Center